8^th Annual Summit on Rare Diseases and Orphan Drugs July 17-18, 2023 London, UK

Sanjay Somasundaram co-founded a technology start-up Eichiba Inc (USA) and learning’s from there helped him closely understand the commercial model of such companies. As a physician, he has experience in the pharmaceutical industry across clinical medicine, research, marketing and access. He was lead for the rare disease access program in Pfizer for five years. He and his co-author have extensively interacted with all stakeholders in the rare disease ecosystem including governments, public health experts, regulators, doctors, caregivers and patients to develop deep insights into their unmet needs and look for potential solutions.

Rare Diseases Eco System

Win is a Junior Doctor at Southend University Hospital (SUH) currently working as a Foundation year 2 doctors within AMU. Aside from her core role, Win is actively involved in the education of her fellow medical students, providing tutoring and mentorship to those around her. To date, she has involved in 2 QIPs including: (1) an audit of CFS adoption and its role in elderly patient care; and (2) Introduction of CAP care bundle sticker by improving usability and adoption of the CURB 65 score for patients with Community Acquired Pneumonia. Before joining SUH, Win worked both as a medical officer at Sakura Private General Hospital, and as a Civil Medical Officer in the Ministry of Health and Sports back in her homeland Myanmar. It was in Myanmar that she found her passion for medicine, after completing her M.B.B.S at the University of Medicine, Mandalay; and later undertaking a foundation year 1 program at a General Hospital operating 1000 beds for patients.

Rare Disorders

Ahmed Hassan obtained his Medical Doctorate at Charles University in Prague. He completed his Internship year at Motol University Hospital and qualified as a Doctor of Medicine. He found a passion for teaching and worked as a lecturer for several years at the Charles University 2nd Faculty of Medicine Department of Anatomy. He currently works as a junior doctor in the Acute Medicine department at Southend University Hospital. Ahmed is frequently involved in teaching medical students and fellow junior doctors. He has a special interest in Rheumatology and the acute presentation of autoimmune diseases. He recently presented a case-series on IgG-4 Related Diseases, and is participating in several research projects with the hopes of starting a career as a physician-scientist.

Rare Genetic Disorder

Rashmi Sharma is Associate Professor Samrat Prithviraj Chauhan Government College, India. She has 28 years teaching and Research experience. She has published more than 30 papers in International journals. She has attended more than 70 International and national conferences. 8 students have completed MPhill under her guidance. 5 Students are doing PhD under her guidance. 2 completed under her guidance. 1 candidate Awarded PhD degree under guidance. She is author of 20 books

Viral diseases and antiviral effect of glycyrrhiza glabra

Christoph Wachsmuth has done his PhD in molecular biology and at present he is the Senior Medical Science Liaison Manager Hematology/Rare Diseases at Takeda Germany (after Shire was taken over by Takeda and he worked under Disease Areas: Hemophilia A and B, von-Willebrand-Disease, Thrombotic-thrombocytopenic purpura (TTP), Gene therapy HämA (AAV5-based) on KOL management, identification, development and Scientific literature update, Organisation of AdBoards, Support of Clinical Studies Phase II-III, Implementation of Takeda Hemophilia Academy, Support of Patients-Organisations North-Germany Hemophilia, Training and support of 6 KAMs.. & He is the Senior Medical Science Liaison Manager Oncology at Shire Deutschland GmbH (after Baxalta was taken over by Shire) Disease Areas and Molecules,Gastroenterology-oncology: Pancreatic cancer (Nal-IRI, Onivyde); Myelofibrosis (pacritinib, JAK2/FLT3-inhibitors), Hematology (ALL, AML; Peg-aspargase, Oncaspar), CAR-T-therapy; NorthgermanyKOL management, identification, development

Rare Diseases

Mathey- Apossan Dodji Eric is the CEO for Sauvons La Vie in Togo and at Present he is the Initiator Project Messengers of HOPE Migrants and sexual behaviour in Switzerland and He is the Program Coordinator Africa DDR Reintegration and Culture of peace of groups at risk Post crisis West Côte d'Ivoire. He is Certification of HIV/AIDS animator city of Columbus State Ohio USA (2007-2010) and CATF Columbus AIDS Task Force. He has Field Agent Certificate - American Red Cross Ohio State USA (2009) and USAID Affiliate Partner Certificate – SFPS Project / AIDS Prevention – Family Planning (1997-2002) and He has CRIPS Trainer / AIDS Prevention Certificate (1996-1998). He has done so many researches and he had done lot of publications and brought awareness with his research. He has fought against the children rights and women rights and Gender Violence.

Rare Diseases